Bristol Myers Squibb Long Term Deferred Assets (Quarterly) Analysis

Bristol Myers Squibb Co. (BMY)

60.66 +0.36 (+0.60%) USD | NYSE | Feb 20, 16:00

60.66 0.00 (0.00%) Pre-Market: 20:00

View Long Term Deferred Assets (Quarterly) for BMY.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Amgen, Inc.	--
Gilead Sciences, Inc.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade
Janux Therapeutics, Inc.	--
Moderna, Inc.	Upgrade